Emerging infectious diseases: A challenge to all

American Family Physician

Volumn 55, Issue 1, 1997, Pages 111-117

  Strausbaugh, Larry J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CLINDAMYCIN; PENICILLIN G; RIBAVIRIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DISEASE TRANSMISSION; EHRLICHIOSIS; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HANTAVIRUS PULMONARY SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; EHRLICHIOSIS; ENTEROCOCCUS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; INCIDENCE; INFECTION; RISK FACTORS; SEROTYPING; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; UNITED STATES; VANCOMYCIN;

EID: 0031032067     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lederberg J, Shope RE, Oaks SC, eds. Emerging infections: microbial threats to health in the United States. Washington, D.C.: National Academy Press, 1992.
2. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta: Centers for Disease Control and Prevention, 1994.
3. Lederber GJ. Infection emergent [Editorial]. JAMA 1996;275:243-5.
4. Serogroup B meningococcal disease - Oregon 1994. MMWR Morb Mortal Wkly Rep 1995;44:121-4.
5. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996;275:199-205.
6. Standaert SM, Dawson JE, Schaffner W, Childs JE, Biggie KL, Singleton J Jr, et al. Ehrlichiosis in a golf-oriented retirement community. N Engl J Med 1995;333:420-5.
7. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
8. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994;120:730-5.
9. Spera RV Jr, Farber BE Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 1992;268:2563-4.
10. Morris JG Jr, Shay DK, Hebden JN, McCarter RJ Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
11. Nosocomial enterococci resistant to vancomycin -United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
12. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
13. Livornese LL Jr, Dias S, Samel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
14. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
15. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44(RR-12):1-13.
16. Simonsen L, Dalton MJ, Breiman RF, Hennessy T, Umland ET, Sewell CM, et al. Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis 1995;172:729-33.
17. Hjelle B, Jenison S, Mertz G, Koster F, Foucar K. Emergence of hantaviral disease in the southwestern United States. West J Med 1994;161:467-73.
18. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-55.
19. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995;333:364-8.
20. Su C, Brandt LJ. Escherichia coli O157:H7 infection in humans. Ann Intern Med 1995;123:698-714.
21. Swerdlow DL, Woodruff BA, Brady RC, Griffin PM, Tippen S, Donnell HD Jr, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med 1992;117:812-9.
22. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-77.
23. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993;269:384-9 [Published erratum appears in JAMA 1993;269:1638].
24. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-5.
25. Defining the group A streptococcal toxic shock syndrome. The Working Group on Severe Streptococcal Infections. JAMA 1993;269:390-1.